[Sensitivity of amoebae of the "limax" group to selected antiparasitic drugs. II. Studies in vivo].
D000562:Amebiasis / Q000188:drug therapy*; D000563:Amebicides / Q000627:therapeutic use*; D000656:Amoeba / Q000187:drug effects*; D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D004351:Drug Resistance; D004709:Endolimax / Q000187:drug effects*; D005260:Female; D008297:Male; D051379:Mice; D010303:Paromomycin / Q000627:therapeutic use; D011112:Polymyxin B / Q000627:therapeutic use
D000563:Amebicides; D010303:Paromomycin; D000666:Amphotericin B; D011112:Polymyxin B
Wrazliwość pełzaków grupy "limax" na wybrane leki przeciwpasozytnicze. II. Badania in vivo.